 Englewood Cliffs, NJ , July 21, 2021 GLOBE NEWSWIRE -- Silo Pharma, Inc. OTCQB: SILO, a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, has announced that the company will be participating in a nationwide media tour on Thursday, July 22 from 8 a.m. 11:30 a.m. EST. 